Behandlingens virkning blev hovedsagelig bedømt efter den andel af patienterne, hos hvem hiv- indholdet i blodet var faldet til under 400 eller 50 kopier/ ml og holdt sig under dette niveau indtil 48. behandlingsuge.
The main measure of effectiveness was the proportion of patients whose HIV levels in the blood (viral loads) had fallen to below 400 or 50 copies/ ml and were maintained below these levels until the 48th week of treatment.